Under the corporate philosophy
of 'Otsuka - people creating new products
for better health worldwide,' Otsuka Pharmaceutical
Co., Ltd. is engaged in the production and
sale of innovative, creative pharmaceuticals,
nutritional products, and cosmetics, aiming
to be a global value-creating company that
contributes to the health and wellness of
people worldwide.
Adults Aripiprazole (Abilify®) is indicated for acute and maintenance treatment of schizophrenia.
Adolescents Aripiprazole (Abilify®) is indicated for the treatment of Schizophrenia in adolescents 13 to 17 years of age.
2. Bipolar Disorder
Monotherapy Aripiprazole(Abilify®) is indicated for acute and maintenance treatment of manic and mixed episodess associated with Bipolar I Disorderwith or without psychotic features in adults and in pediatric patients 10 to 17 years of age.
AdjunctiveTherapy
Aripiprazole (Abilify®) is indicated as an adjunctive therapy to either lithium or valproate for the acute treatment of manic and mixed episodes associated with Bipolar I Disorder with or without the psychotic features in adults and in pediatric patients 10 to 17 years of age.
3. Adjunctive Treatment of Major Depressive Disorder
Adults
Aripiprazole
(Abilify®) is indicated for use as an adjunctive treatment to antidepressants for Major Depressive Disorder.
.gif){kind=small}